GENASSIST
GenAssist provides maintenance and repair services to industrial generators and backup power solutions, as well as equipment sales in New York and New Jersey.
GENASSIST
Industry:
Energy Industrial Service Industry
Address:
New York, New York, United States
Country:
United States
Status:
Active
Similar Organizations
Bücker & Essing
Bücker & Essing provides maintenance and repair services to natural gas, biogas and special gas engines.
On Call Power
On Call Power provides maintenance and repair services to industrial generators and backup power solutions.
More informations about "GenAssist"
Genassisttx
Founded in July 2020, GenAssist Ltd. (GenAssist) is a pioneering gene editing drug company. The operation entity of GenAssist is located in Suzhou, China, with two subsidiaries in …See details»
GenAssist Therapeutics - Crunchbase Company Profile …
GenAssist Therapeutics develops gene therapy drugs using base editing technology, which is advantageous in the field of DMD treatment. Founded in …See details»
GenAssist, a Pioneer in the field of the Gene Editing Innovative …
Dec 14, 2023 On July 9, 2021, GenAssist has successfully closed a multi-million RMB Pre-Series A financing , bringing the total raised funds to nearly 100 million RMB.The round was …See details»
GEN6050 - Drug Targets, Indications, Patents - Synapse
Suzhou GenAssist owns the global rights of TAM base editor, which is licensed from Chinese Academy of Nutrition and Health and Westlake University. Suzhou GenAssist Therapeutic is …See details»
GenAssisst Ltd announced the successful kickoff meeting of …
Jun 19, 2024 On May 30, 2024, Suzhou GenAssist Therapeutical Co., Ltd, the operation entity of GenAssist Ltd (GenAssist), announced that the IIT(NCT06392724) kickoff meeting for its first …See details»
GenAssist Therapeutics - PitchBook
GenAssist Therapeutics General Information Description. Developer of gene editing drugs for a variety of genetic diseases. The company owns global intellectual property rights of TAM (Targeted AID-based Mutagenesis) base …See details»
GENASSIST - Crunchbase Company Profile & Funding
Organization. GENASSIST . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... GENASSIST closed its last funding round on May 1, …See details»
GenAssist Therapeutics - Funding, Financials, Valuation & Investors
Dec 8, 2022 GenAssist Therapeutics has raised 2 rounds. Their latest funding was raised on Dec 8, 2022 from a Series A round. GenAssist Therapeutics is funded by 4 investors. …See details»
GenAssist Raises “Millions of Dollars” for Novel Base Editing Drugs
Dec 8, 2022 Suzhou GenAssist Therapeutics raised “millions of dollars” in an A round to support its gene editing drugs that target neuromuscular diseases. Founded in 2020, the company …See details»
WuXi ATU and Suzhou GenAssist Therapeutics Announce Strategic ...
About Suzhou GenAssist Therapeutics Co., Ltd. (GenAssist) ... Development and Manufacturing Organization (CTDMO) that offers integrated platforms to transform the discovery, …See details»
GenAssist
GenAssist Inc. Providing a New Therapy for Muscle Trauma . The First Company to Restore Muscle . Today Over 250,000 traumatic muscle injuries every year. 60% of muscle trauma …See details»
GENASSIST - Funding, Financials, Valuation & Investors - Crunchbase
GENASSIST is a genetics company that provides assisted reproductive technology genetic consultation and testing services. Search Crunchbase. Start Free Trial . ... How much funding …See details»
GenAssist testing support program - Login
The eligibility criteria for genetic testing for each province are guidelines based on current medical evidence, recommendations established by provincial Ministries of Health, and …See details»
GenAssisst Ltd announced the Pre-IND meeting request submitted …
On July 29, 2024, Suzhou GenAssist Therapeutical Co., Ltd, the operation entity of GenAssist Ltd (GenAssist), announced that Pre-IND (PIND) meeting request for its first base editing DMD …See details»
GenAssist Completes Multi-Million Dollar Series A Financing
Dec 14, 2023 Recently, GenAssist, which is the first company in China to develop gene therapy drugs using base editing technology, announced the closing of a multi-million dollar Series A …See details»
GENASSIST™ - Enabling Gene Editing For Everyone - Mr. E Rhodes
Mar 5, 2014 GENASSIST™ CRISPR and rAAV gene editing tools and services from Horizon: Enabling gene editing for everyone.Join us to learn about GENASSIST™, a range of gen...See details»
Series A - GenAssist Therapeutics - 2022-12-08 - Crunchbase
Dec 8, 2022 Organization Name . GenAssist Therapeutics . Announced Date Dec 8, 2022; Closed On Date Dec 8, 2022; Funding Type Series A; Funding Stage Early Stage Venture; …See details»
GenAssist: Making Image Generation Accessible - ACM Digital …
Nov 1, 2023 As GenAssist exists in an ableist environment that prioritizes visual communication, there is a risk that GenAssist may cause sighted people to expect image-based …See details»
GenAssist - Crunchbase Company Profile & Funding
Legal Name GenAssist Inc. Phone Number (573) 275-4972 GenAssist began commercializing biomimetic sponges to treat muscle loss in human patients after observing a notable recovery …See details»
GenAssist - Crunchbase Company Profile & Funding
Organization. GenAssist . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. ... GenAssist is located in New York, New York, United States. Who are …See details»